These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 816715

  • 21. [Determination of fibrin fibrinogen degradation products in urine after kidney allotransplantation].
    Drannik GN, Ena IaM, Glukhen'kaia ZE.
    Lab Delo; 1978; (5):266-71. PubMed ID: 79008
    [No Abstract] [Full Text] [Related]

  • 22. [Inhibition of leukocyte migration, complement fixing antibodies and fibrinogen fibrin split products in the urine of patients after cadaver kidney transplantation].
    Drannik GN, Baran EIa.
    Urol Nefrol (Mosk); 1978; (3):18-21. PubMed ID: 351908
    [No Abstract] [Full Text] [Related]

  • 23. [Expression of human fibrinogen-like protein 2/fibroleukin in renal acute allograft rejection and its potential clinical implication].
    Zhang L, Ning Q, Guo H, Zhang WJ, Chen F, Luo XP.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 17; 84(6):474-7. PubMed ID: 15061965
    [Abstract] [Full Text] [Related]

  • 24. [Urinary and serum fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T, Kaneko S, Iguchi M, Minami K, Kadowaki T.
    Nihon Hinyokika Gakkai Zasshi; 1977 Jun 17; 68(6):599-608. PubMed ID: 335137
    [No Abstract] [Full Text] [Related]

  • 25. Daily immunologic tests in the prediction of renal transplant rejection.
    Wood RF, Gray AC, Bell PR.
    Transplant Proc; 1978 Sep 17; 10(3):593-4. PubMed ID: 362640
    [No Abstract] [Full Text] [Related]

  • 26. Mechanism of platelet aggregation and release: their possible role in vascular injury.
    Ardlie NG.
    Perspect Nephrol Hypertens; 1973 Sep 17; 1 Pt 2(0):891-905. PubMed ID: 4610504
    [No Abstract] [Full Text] [Related]

  • 27. [Antithrombotic preparations in the combined therapy of the acute reaction of the rejection of a kidney allograft].
    Baran EIa, Krimkevich EI, Zograb'ian RO.
    Urol Nefrol (Mosk); 1988 Sep 17; (5):6-10. PubMed ID: 3061127
    [No Abstract] [Full Text] [Related]

  • 28. The clinical significance of urinary fibrinopeptide A and fibrinopeptide B-beta 15-42 in chronic rejection and nephrotoxicity of renal allograft recipients immunosuppressed with cyclosporine.
    Morozumi K, Kano T, Kobayashi M, Shinmura I, Yoshida A, Fujinami T, Otaguro K, Uchida K, Yamada N, Tominaga Y.
    Transplant Proc; 1987 Feb 17; 19(1 Pt 2):1791-4. PubMed ID: 3547884
    [No Abstract] [Full Text] [Related]

  • 29. Fibrinolytic degradation products in urine of anticoagulated transplant patients.
    Aguilo JJ, Bowie EJ, Woods JE, Owen CA.
    Eur Urol; 1978 Feb 17; 4(1):46-9. PubMed ID: 342250
    [Abstract] [Full Text] [Related]

  • 30. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM, Ofstad J, Thunold S, Willassen Y.
    Tidsskr Nor Laegeforen; 1976 Jan 20; 96(2):91-3. PubMed ID: 766292
    [No Abstract] [Full Text] [Related]

  • 31. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT, Tubbs RS, Shoja MM, Ghafari A, Noshad H, Ardalan MR.
    Transplant Proc; 2008 Jan 20; 40(1):137-9. PubMed ID: 18261569
    [Abstract] [Full Text] [Related]

  • 32. A study of renal allograft rejection in the rat using 125I-fibrinogen.
    Salaman JR.
    Br J Surg; 1972 Apr 20; 59(4):311. PubMed ID: 4553599
    [No Abstract] [Full Text] [Related]

  • 33. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation.
    Ekberg M, Bergentz SE, Hedner U, Nilsson IM.
    Scand J Urol Nephrol; 1976 Apr 20; 10(1):56-62. PubMed ID: 775625
    [Abstract] [Full Text] [Related]

  • 34. [Fibrinogen-fibrin degradation products in the urine. Measurement and characterization by means of electroimmunodiffusion (rapid method)].
    Thöni RF, Grob PJ.
    Schweiz Med Wochenschr; 1973 Jul 07; 103(27):965-9. PubMed ID: 4146017
    [No Abstract] [Full Text] [Related]

  • 35. Proceedings: Canine renal allograft rejection: evaluation of progressive microsvacular thrombosis.
    Webster WP, Mandel SR, Staab EV, Clark RL.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):604. PubMed ID: 1105883
    [No Abstract] [Full Text] [Related]

  • 36. The role of coagulation in the obliteration of glomerular capillaries.
    Kincaid-Smith P.
    Perspect Nephrol Hypertens; 1973 Nov 15; 1 Pt 2(0):871-90. PubMed ID: 4610503
    [No Abstract] [Full Text] [Related]

  • 37. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients.
    Helantera I, Koskinen P, Tornroth T, Loginov R, Gronhagen-Riska C, Lautenschlager I.
    Transplantation; 2003 Jun 15; 75(11):1858-64. PubMed ID: 12811246
    [Abstract] [Full Text] [Related]

  • 38. Intravascular coagulation (IVC) in human renal allograft rejection.
    Busch GJ, Braun WE, Carpenter CB, Corson JM, Galvanek ER, Reynolds ES, Merrill JP, Dammin GJ.
    Transplant Proc; 1969 Mar 15; 1(1):267-70. PubMed ID: 4944225
    [No Abstract] [Full Text] [Related]

  • 39. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S, Alexander JW, Schroeder TJ, First MR.
    Clin Transplant; 1996 Dec 15; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [Abstract] [Full Text] [Related]

  • 40. [Causes of late renal transplant dysfunction].
    Szabó A, Müller V.
    Orv Hetil; 2002 Dec 22; 143(51):2811-9. PubMed ID: 12638307
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.